- Home
- UUU vs VYNE Comparison
UUU vs VYNE Comparison
Compare UUU & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.65
HOLD
Current Price
$0.65
Company Overview
Basic Information| Metric | UUU | VYNE |
|---|---|---|
| Founded | 1969 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 22.3M |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | UUU | VYNE |
|---|---|---|
| Price | $6.65 | $0.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.3K | ★ 141.3K |
| Earning Date | 02-19-2026 | 05-08-2026 |
| Dividend Yield | ★ 16.75% | N/A |
| EPS Growth | ★ 229.41 | 33.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $23,563,554.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.39 | N/A |
| 52 Week Low | $2.82 | $0.29 |
| 52 Week High | $8.27 | $1.96 |
Technical Indicators
Market Signals| Indicator | UUU | VYNE |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 43.78 |
| Support Level | $5.72 | $0.56 |
| Resistance Level | $7.55 | $0.69 |
| Average True Range (ATR) | 0.57 | 0.02 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 12.03 | 41.77 |
Price Performance
Historical Comparison UUU
VYNE
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.